7-Chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione

Catalog No.: 
ACCMKV317
CAS No.: 
25710-21-8
Molecular Formula: 
C7H4ClN3O2
Molecular Weight: 
197.58
7-Chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
IUPAC Name7-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
Molecular FormulaC7H4ClN3O2
Molecular Weight197.58
SMILESO=C1NC2=CC(Cl)=CN=C2NC1=O
InChI KeyYFWLSZXJLSPXTO-UHFFFAOYSA-N
Synonym7-Chloro-1,4-dihydro-pyrido[2,3-b]pyrazine-2,3-dione;7-chloropyrido[2,3-b]pyrazine-2,3-diol;Pyrido[2,3-b]pyrazine-2,3-dione, 7-chloro-1,4-dihydro-;7-chloropyrido[2,3-b]pyrazine-2,3(1H,4H)-dione
CAS No.25710-21-8

Synthetic Route by SureRoute

1. ACCMKV317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOCF813 route compound structure diagram
    ACTOCF81325710-20-7In Stock
  2. Plus
  3. ACBGEI741 route compound structure diagram
    ACBGEI741547-68-2In Stock
  4. Then
  5. ACCMKV317 route product structure diagram
    ACCMKV31725710-21-8
Inquiry

2. ACCMKV317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACTOCF813 route compound structure diagram
    ACTOCF81325710-20-7In Stock
  6. Then
  7. ACCMKV317 route product structure diagram
    ACCMKV31725710-21-8
Inquiry

3. ACCMKV317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOCF813 route compound structure diagram
    ACTOCF81325710-20-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMKV317 route product structure diagram
    ACCMKV31725710-21-8
Inquiry

Comments (0)